Soluble CD163 levels in children with sickle cell disease

British Journal of Haematology

Volumn 153, Issue 1, 2011, Pages 105-110

  Moller, Holger Jon ^a   Nielsen, Marianne Jensby ^a   Bartram, Jack ^b   Dick, Moira C ^b   Height, Susan E ^b   Moestrup, Soren K ^a   Rees, David C ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

CD163; Haemolysis; Sickle cell disease; Vasculopathy

Indexed keywords

BIOLOGICAL MARKER; CD163 ANTIGEN; HAPTOGLOBIN; HYDROXYUREA; LACTATE DEHYDROGENASE;

ARTICLE; BLOOD ANALYSIS; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; HEMOGLOBINOPATHY; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; SICKLE CELL ANEMIA; STEADY STATE;

ADOLESCENT; ANEMIA, SICKLE CELL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ANTISICKLING AGENTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DRUG MONITORING; FEMALE; HAPTOGLOBINS; HEMOLYSIS; HUMANS; HYDROXYUREA; MALE; RECEPTORS, CELL SURFACE; SOLUBILITY;

EID: 79952609443     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08580.x     Document Type: Article

References (24)

1. Aristoteli, L.P., Moller, H.J., Bailey, B., Moestrup, S.K. & Kritharides, L. (2006) The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis. Atherosclerosis, 184, 342-347.
2. Belcher, J.D., Bryant, C.J., Nguyen, J., Bowlin, P.R., Kielbik, M.C., Bischof, J.C., Hebbel, R.P. & Vercellotti, G.M. (2003) Transgenic sickle mice have vascular inflammation. Blood, 101, 3953-3959.
3. Bernini, J.C., Rogers, Z.R., Sandler, E.S., Reisch, J.S., Quinn, C.T. & Buchanan, G.R. (1998) Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood, 92, 3082-3089.
4. Bover, L.C., Cardó-Vila, M., Kuniyasu, A., Sun, J., Rangel, R., Takeya, M., Aggarwal, B.B., Arap, W. & Pasqualini, R. (2007) A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications. Journal of Immunology, 178, 8183-8194.
5. Bunn, H.F., Nathan, D.G., Dover, G.J., Hebbel, R.P., Platt, O.S., Rosse, W.F. & Ware, R.E. (2010) Pulmonary hypertension and nitric oxide depletion in sickle cell disease. Blood, 116, 687-692.
6. Fabriek, B.O., Polfliet, M.M., Vloet, R.P., van der Schors, R.C., Ligtenberg, A.J., Weaver, L.K., Geest, C., Matsuno, K., Moestrup, S.K., Dijkstra, C.D. & van den Berg, T.K. (2007) The macrophage CD163 surface glycoprotein is an erythroblast adhesion receptor. Blood, 109, 5223-5229.
7. Fabriek, B.O., van Bruggen, R., Deng, D.M., Ligtenberg, A.J., Nazmi, K., Schornagel, K., Vloet, R.P., Dijkstra, C.D. & van den Berg, T.K. (2009) The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. Blood, 113, 887-892.
8. Gladwin, M.T., Sachdev, V., Jison, M.L., Shizukuda, Y., Plehn, J.F., Minter, K., Brown, B., Coles, W.A., Nichols, J.S., Ernst, I., Hunter, L.A., Blackwelder, W.C., Schechter, A.N., Rodgers, G.P., Castro, O. & Ognibene, F.P. (2004) Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. New England Journal of Medicine, 350, 886-895.
9. Griffin, T.C., McIntire, D. & Buchanan, G.R. (1994) High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease. New England Journal of Medicine, 330, 733-737.
10. Hogger, P. & Sorg, C. (2001) Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation. Biochemical and Biophysical Research Communications, 288, 841-843.
11. Kato, G.J., McGowan, V., Machado, R.F., Little, J.A., Taylor, J., Morris, C.R., Nichols, J.S., Wang, X., Poljakovic, M., Morris, S.M. & Gladwin, M.T. (2006) Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood, 107, 2279-2285.
12. Kristiansen, M., Graversen, J.H., Jacobsen, C., Sonne, O., Hoffman, H.J., Law, S.K. & Moestrup, SK. (2001) Identification of the haemoglobin scavenger receptor. Nature, 409, 198-201.
13. Moller, H.J., Peterslund, N.A., Graversen, J.H. & Moestrup, S.K. (2002) Identification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasma. Blood, 99, 378-380.
14. Moller, H.J., de Fost, M., Aerts, H., Hollak, C. & Moestrup, S.K. (2004) Plasma level of the macrophage-derived soluble CD163 is increased and positively correlates with severity in Gaucher's disease. European Journal of Haematology, 72, 135-139.
15. Moller, H.J., Moestrup, S.K., Weis, N., Wejse, C., Nielsen, H., Pedersen, S.S., Attermann, J., Nexo, E. & Kronborg, G. (2006) Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163. Critical Care Medicine, 34, 2561-2566.
16. Moller, H.J., Gronbaek, H., Schiodt, F.V., Holland-Fischer, P., Schilsky, M., Munoz, S., Hassanein, T. & Lee, W.M.; U.S. Acute Liver Failure Study Group. (2007) Soluble CD163 from activated macrophages predicts mortality in acute liver failure. Journal of Hepatology, 47, 671-676.
17. Moller, H.J., Nielsen, M.J., Maniecki, M.B., Madsen, M. & Moestrup, S.K. (2010) Soluble macrophage-derived CD163: a homogenous ectodomain protein with a dissociable haptoglobin-hemoglobin binding. Immunobiology, 215, 416-412.
18. Moreno, J.A., Dejouvencel, T., Labreuche, J., Smadja, D.M., Dussiot, M., Martin-Ventura, J.L., Egido, J., Gaussem, P., Emmerich, J., Michel, J.B., Blanco-Colio, L.M. & Meilhac, O. (2010) Peripheral artery disease is associated with a high CD163/TWEAK plasma ratio. Arteriosclerosis, Thrombosis and Vascular Biology, 30, 1253-1262.
19. O'Driscoll, S., Height, S.E., Dick, M.C. & Rees, D.C. (2008) Serum lactate dehydrogenase deficiency as a biomarker in children with sickle cell disease. British Journal of Haematology, 140, 206-209.
20. Podmore, A.H.B., Dalton, S., Henthorn, J.S. & Davies, S.C. (2007) Levels of haptoglobin and haemopexin in patients with sickle and other haemolytic diseases, and haptoglobin genotype frequency. British Journal of Haematology, 137, 71.
21. Reiter, C.D., Wang, X., Tanus-Santos, J.E., Hogg, N., Cannon, R.O. III, Schechter, A.N. & Gladwin, M.T. (2002) Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nature Medicine, 8, 1383-1389.
22. Schaer, D.J., Boretti, F.S., Schoedon, G. & Schaffner, A. (2002) Induction of the CD163-dependent haemoglobin uptake by macrophages as a novel anti-inflammatory action of glucocorticoids. British Journal of Haematology, 119, 239-243.
23. Van Gorp, H., Delputte, P.L. & Nauwynck, H.J. (2010) Scavenger receptor CD163, a jack-of-all-trades and potential target for cell-directed therapy. Molecular Immunology, 47, 1650-1660.
24. Weaver, L.K., Hintz-Goldstein, K.A., Pioli, P.A., Wardwell, K., Qureshi, N., Vogel, S.N. & Guyre, P.M. (2006) Pivotal advance: activation of cell surface Toll-like receptors causes shedding of the hemoglobin scavenger receptor CD163. Journal of Leukocyte Biology, 80, 26-35.